NTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Nutrien Ltd (NTR) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, share repurchase program, and favorable analyst ratings indicate positive long-term prospects. While hedge funds are selling, insider activity remains neutral, and the technical indicators suggest a bullish trend. The stock is trading near a resistance level, but the overall sentiment and fundamentals support a buy decision.
The stock shows a bullish trend with moving averages (SMA_5 > SMA_20 > SMA_200). The RSI is neutral at 67.198, and the MACD histogram is slightly negative at -0.0407 but contracting. Key resistance levels are at 73.076 and 74.143, with support at 69.623 and 68.556. The stock is trading near its first resistance level in pre-market.
Nutrien's share repurchase program demonstrates confidence in the stock and commitment to shareholders.
Strong Q4 financial performance with significant YoY growth in revenue (+5.14%), net income (+405.31%), and EPS (+413.04%).
Analysts have raised price targets, with several maintaining Buy or Outperform ratings.
Bullish technical indicators and favorable long-term growth prospects in the agriculture sector.
Hedge funds are selling, with a 116.85% increase in selling activity last quarter.
BNP Paribas downgraded the stock to Neutral, citing headwinds in the fertilizer market.
Short-term stock trend analysis indicates a potential minor decline in the next day (-0.48%) and week (-1.33%).
In Q4 2025, Nutrien reported strong financial growth: Revenue increased by 5.14% YoY to $5.34 billion, net income surged by 405.31% YoY to $571 million, EPS rose by 413.04% YoY to $1.18, and gross margin improved by 13.59% YoY to 35.36%.
Analysts are generally positive on Nutrien, with multiple firms raising price targets recently. RBC Capital raised its target to $80, citing operational improvements and strong cash flow growth. JPMorgan and TD Securities also raised targets to $78 and $81, respectively, with Buy or Overweight ratings. However, BNP Paribas downgraded the stock to Neutral, citing headwinds in the fertilizer market.
